Company: FVN
Filing Date: 2025-04-14
Form Type: DRS/A
Source: 0001829126-25-002616
Chunk: 78

Company: Future Vision II Acquisition Corp.
Filing Date: 2025-04-14
Form: DRS/A
Chunk 78
---
 directors own Future Vision Shares which will not participate in liquidation distributions and, therefore, they will lose their entire investment in us and face other financial consequences if the Business Combination is not completed, they may have a conflict of interest in determining whether the Business Combination is appropriate. |

| ● | Future Vision is requiring Shareholders who wish to redeem their Future Vision ordinary shares in connection with the Business Combination to comply with specific requirements for redemption that may make it more difficult for them to exercise their redemption rights prior to the deadline for exercising their rights.                               |
| ● | Future Vision will require its Shareholders who wish to redeem their Ordinary Share in connection with the Business Combination to comply with specific requirements for redemption described above, and such redeeming Shareholders may be unable to sell their securities when they wish to in the event that the Business Combination is not consummated. |
| ● | Future Vision’s Sponsor, including its officers and directors, have agreed to vote their shares in favor of the Business Combination, regardless of how the Public Shareholders vote.                                                                                                                                                                        |
| ● | If Future Vision’s security holders exercise their registration rights with respect to their securities, it may have an adverse effect on the market price of Future Vision’s securities.                                                                                                                                                                    |

| ● | Future Vision will be unable to close the Business Combination if the redemptions of public shares result in its Net Tangible Assets being less than $5,000,001 unless it is able to obtain sufficient equity financing. |

Risks Related to the Financial Projections

<div align='center'>39</div>

Risk Factors Relating to an Investment in New VIWO’s Ordinary Shares

| ● | Certain judgments obtained against us by New VIWO’s shareholders may not be enforceable. |

| ● | New VIWO’s Key Projected Financial Metrics are subject to significant risks, assumptions, estimates and uncertainties, including assumptions regarding future market and changes in regulations. As a result, New VIWO’s projected revenues, market share, expenses and profitability may differ materially from its expectations. |

| ● | If a public market for New VIWO’s ordinary shares does not develop, investors may not be able to re-sell their ordinary shares, rendering their shares illiquid and possibly resulting in a complete loss of their investment. |

| ● | New VIWO may be unable to obtain additional financing to fund its operations or growth. |

| ● | New VIWO may be subject to securities litigation, which is expensive and could divert management attention. |

| ● | If securities or industry analysts